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synergizes with leptin to regulate feeding.
These findings provide a potential
mechanism for the increased efficacy of
amylin and leptin combination therapy for
obesity.
Cell Metabolism
Short ArticleHypothalamic Amylin Acts in Concert
with Leptin to Regulate Food Intake
Zhiying Li,1 Leah Kelly,1 Ibrahim Gergi,2 Patrik Vieweg,2 Myriam Heiman,3 Paul Greengard,4
and Jeffrey Michael Friedman1,5,*
1Laboratory of Molecular Genetics, The Rockefeller University, New York, NY 10065, USA
2Linko¨ping University, Linko¨ping 581 83, Sweden
3Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02138, USA
4Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065, USA
5Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789, USA
*Correspondence: friedj@rockefeller.edu
http://dx.doi.org/10.1016/j.cmet.2015.10.012SUMMARY
In this report we evaluated the functions of hypo-
thalamic amylin in vivo and in vitro. Profiling of
hypothalamic neurons revealed that islet amyloid
polypeptide (Iapp, precursor to amylin) is expressed
in neurons in the lateral hypothalamus, arcuate nu-
cleus, medial preoptic area, and elsewhere. Hypo-
thalamic expression of lapp is markedly decreased
in ob/ob mice and normalized by exogenous leptin.
In slices, amylin and leptin had similar electrophysio-
logic effects on lateral hypothalamic leptin receptor
ObRb-expressing neurons, while the amylin antago-
nist AC187 inhibited their activity and blunted the ef-
fect of leptin. Finally, i.c.v. infusion of AC187 acutely
reduced the anorectic effects of leptin. These data
show that hypothalamic amylin is transcriptionally
regulated by leptin, that it can act directly on ObRb
neurons in concert with leptin, and that it regulates
feeding. These findings provide a potential mecha-
nism for the increased efficacy of a metreleptin/
pramlintide combination therapy for obesity.
INTRODUCTION
Prodynorphin (Pdyn), precursor of the dynorphin family of the
opioid peptides, regulates diverse physiological processes
including pain, stress and anxiety, learning and memory, alcohol
consumption, hippocampal epilepsy, and withdrawal from nar-
cotics (Wang et al., 2001; McLaughlin et al., 2003; Blednov
et al., 2006; Loacker et al., 2007; Wittmann et al., 2009; Chefer
and Shippenberg, 2006; Shin et al., 2009). Recently we found
that Pdyn neurons in the dorsal medial hypothalamus (DMH)
play a role in the feeding response to a scheduled feeding proto-
col that elicits food anticipatory activity (Knight et al., 2012), while
deleting leptin receptor ObRb in Pdyn neurons led to increased
body weight gain upon high-fat diet (HFD) treatment (Allison
et al., 2015). We thus set out to study the role of Pdyn neurons
in feeding by profiling their pattern of expression using TRAP
technology. In the course of these studies, we found that a sub-Cell Metabset of lateral hypothalamic (LH) Pdyn neurons expresses Islet
amyloid polypeptide (Iapp), also known as Amylin, a peptide pre-
viously shown to be expressed in pancreatic b cells. While some
studies have suggested that Iapp is expressed in the CNS,
others do not (Leffert et al., 1989; Ferrier et al., 1989). Amylin is
approved for the treatment of diabetes. Importantly, amylin has
been reported to synergize with leptin to reduce body weight
in obese animals and humans (Roth et al., 2008), though the
mechanism is not fully understood. We thus set out to confirm
the expression of amylin in the CNS and evaluate its effects on
neural circuits that control feeding.
RESULTS
Identification of Hypothalamic Iapp Expression
We profiled hypothalamic Pdyn neurons by TRAP technology
using Pdyn-eGFP-L10 transgenic mice (Heiman et al., 2008).
We first confirmed that there was eutopic expression of GFP in
Pdyn-eGFP-RPL10aBACtransgenicmiceby immunohistochem-
istry (IHC; see Figure S1 available online). We found that Pdyn is
expressed in hypothalamic paraventricular nucleus (PVN), LH,
DMH, ventral medial hypothalamus (VMH), and Arc. The expres-
sion of GFP overlaps extensively with the published fluorescence
in situ hybridization data for Pdyn (Allen Brain Atlas, mouse.
brain-map.org) and IHC for dynorphin A (Dyn A). Leptin i.p. led
to phosphorylation of signal transducer andactivator of transcrip-
tion 3 (STAT3) in a subset of Arc Pdyn neurons (11.39%± 0.91%,
n = 2; Figure S1C), indicating Pdyn neurons respond to leptin.
Triplicates of paired wild-type hypothalamic IP and Input RNA
sampleswere assayed forPdyn-enriched transcripts. 13822 pro-
besets out of 45101 were present in the Pdyn transcriptome (Fig-
ure S2A), among which 1,729 probe sets showed a fold change
(FC) > = 2. These probe sets revealed 172 GO terms (Table S1).
Among Pdyn-enriched transcripts, 11 were known neuropep-
tides (Figure S2A, red dots, and Figure S2B; Table S2), and nine
were verified by IHC (Figure S2C): Pdyn, Orx in the LH, arginine
vasopressin (AVP), oxytocin (Oxt), galanin (Gal) and corticotropin
releasing hormone (Crh) in the PVN, and pro-opiomelanocortin-
alpha (POMC) in the Arc. However, the highest enrichment was
observed for Iapp (35, 55, 420, and 553 folds for 4 different probe
sets detecting this transcript). Iapp is the precursor for amylin, a
peptide coexpressed with insulin in pancreatic b cells, and previ-
ous analyses on brain Iapp expression have yielded conflictingolism 22, 1059–1067, December 1, 2015 ª2015 Elsevier Inc. 1059
results. Thus its expression or function in the CNS remains un-
clear. Since our data suggested that in addition to its known
expression in pancreas, Iapp is also expressed in hypothalamic
Pdyn neurons (Figure S3), we set out to confirm its brain expres-
sion and evaluate its function.
Profiling hypothalamic Pdyn neurons in ob/obmice further re-
vealed 16 transcripts that were either up or downregulated (Fig-
ure S2D, red dots, and Figure S2E; Table S3), including Iapp,
which showed a 43- to 1,128-fold decrease (Figure 2A). No sig-
nificant difference was detected betweenWT Input and ob Input,
suggesting this downregulation was specific for Iapp in Pdyn
neurons (Figure S2B). These data suggested that hypothalamic
amylin, possibly coexpressed in LH Pdyn neurons, could play
a role to regulate feeding and leptin action.
Hypothalamic Distribution of Iapp-Expressing Neurons
IHC using an anti-amylin antibody revealed that Iapp was abun-
dantly expressed in multiple hypothalamic nuclei including cell
bodies in MPO, Arc, and LH and fibers in PVN, DMH (Figure 1A).
We next analyzed the coexpression of Iapp with other hypotha-
lamic peptides known to regulate feeding. Consistent with the
aforementioned profiling data, Iapp and Pdyn were coexpressed
only in the LH and MPO. Substantial overlap was also observed
between Iapp and Orx in the LH, while colocalization with MCH,
another peptide expressed in the LH, was not observed (Figures
1B and 1C), and30%of LHPdyn neurons did not express either
Iapp orOrx. Limited colocalizationwas observed in the ArcObRb
neurons (Figure 1D), with partial coexpression in agouti-related
protein (AgRP) but not POMC neurons (Figure 1E). Finally, while
Iappwasnot expressed in LHObRbneurons, amylin immunopos-
itive fibers forming vGat immunopositive synapse-like structures
onto LH ObRb neurons were observed (Figure 1F), suggesting
direct innervation from Iappneurons toObRbcells.ObRbneurons
coexpressing neurotensin in the LH have been shown to regulate
metabolism and inhibit Orx neurons (Leinninger et al., 2011).
Sexually Dimorphic Expression of Hypothalamic Iapp
in Wild-Type Mice and Its Regulation by Leptin and
High-Fat Diet
Wenext assessedwhether the level of Iapp gene expression was
altered in obese mice. In our initial BAC TRAP analyses, the RNA
level for hypothalamic Iapp was higher in wild-type female mice
than males. This was confirmed using qPCR (Figure 2B). This
finding is in line with previous data showing that MPO expression
of Iapp is seen only in postpartum female rats but not in virgin fe-
male or male rats (Dobolyi, 2009). We thus analyzed RNA levels
in obese mice of both sexes.
We found that hypothalamic Iapp mRNA was significantly
reduced in female ob/ob versus female WT mice (Figure 2C).
The levels of RNA in WT male mice were similar to those in
ob/ob mice of both sexes. Thus, because the levels of hypotha-
lamic Iapp in WT male mice are low, a significant effect of the ob
mutation to further lower the levels was not observed. In
contrast, plasma amylin, which reflects the levels of pancreatic
amylin, was significantly higher in both female and male ob/ob
versus WT mice (Figure 2E).
Treatment of ob/obmice with recombinant leptin for 3 months
led to significant increase of hypothalamic IappmRNA in female
ob/ob mice (p < 0.05, Figure 2F) and a small mRNA increase in1060 Cell Metabolism 22, 1059–1067, December 1, 2015 ª2015 Elsemale ob/ob mice which was not significant. This response was
not observed after treatment for 3 or 15 days (data not shown).
We also found that hypothalamic Iapp levels were significantly
increased in both female and male ob/ob mice carrying a leptin
transgene that leads to constitutively high levels of this hormone
(Ribeiro et al., 2011; Figure 2G).
The expression of hypothalamic Iappwas also sexually dimor-
phic in diet-induced obese (DIO) mice. Hypothalamic Iapp
expression was decreased in female DIO mice fed a HFD for
26 weeks and paradoxically significantly increased in male DIO
mice (Figure 2I). A HFD also significantly increased islet Iapp
expression in female but not in malemice, but there were not sig-
nificant differences in plasma amylin concentration in either
gender (Figures 2J and 2K).
Effects of Leptin, Amylin, and AC187 on LH ObRb
Neurons
We next tested the effect of amylin on LH ObRb neurons in slice
preparations. Patch-clamp recordings showed ObRb neurons
were depolarized at baseline (57.95 mV ± 0.88, n = 41), with
a relatively high firing rate (8.46 Hz ± 0.88, n = 33). Bath leptin
(100 nM) excited 65% and inhibited 35% of ObRb neurons (Fig-
ures 3A–3C). Similarly, bath amylin (100 nM) excited 62% and in-
hibited 38% of ObRb neurons (Figures 3A–3C). The effects of
leptin and amylin were significantly correlated for individual neu-
rons exposed to both treatments (Figure 3D), indicating that
amylin depolarizes the same neurons that are depolarized by
leptin and hyperpolarizes neurons that are hyperpolarized by
leptin. This suggests that, similar to their synergistic effects on
food intake and body weight, leptin and amylin could have syn-
ergistic effects on these LH neurons.
The effects of leptin were next tested in the presence of the
amylin antagonist AC187. AC187 (100 nM) significantly inhibited
the effects of leptin on both leptin-depolarizing and hyperpolariz-
ing neurons. In addition, AC187 alone also inhibited leptin-depo-
larizedObRbneurons and activated leptin-hyperpolarizingObRb
neurons (Figures 3E and 3F), suggesting that endogenous amylin
tonically regulates the activity of these leptin regulated neurons.
Voltage-clamp recordings confirmed thatObRb neurons receive
spontaneous excitatory inputs (Figure 3G). However, bath leptin
or amylin did not significantly change sEPSC amplitudes in these
neurons (bottom right panels), suggesting that both leptin and
amylin exert their effects postsynaptically. In aggregate, these
data predict that inhibition of amylin action should blunt the
response to leptin in vivo.
AC187 Antagonizes Leptin’s Anorexic Effect in Mice
We measured food intake in ad lib fed wild-type mice treated
with i.c.v. AC187 or PBS in the lateral ventricle prior to treatment
with i.p. leptin or PBS. In the absence of AC187, leptin signifi-
cantly suppressed food intake (Figure 4A). Pretreatment with
AC187 significantly blunted the anorectic effect of i.p. leptin
with intakes similar to i.p. PBS control mice. Consistent with
the in vitro effect of AC187 alone to alter neural activity, AC187
also increased food intake in mice treated with i.p. PBS by
1.5-fold during the first 2 hr (Figures 4A and 4B). In both cases,
however, the effect of the antagonist was transient. This is likely a
result of leptin action on other brain regions such as Arc and/or
the clearance of AC187.vier Inc.
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Figure 1. IHC Characterization of Hypothalamic Iapp Expression
(A) Hypothalamic slices from adult Pdyn BAC TRAP mice were stained for GFP (green) and Iapp (red). Scale bars, 100 mm.
(B) IHC for GFP (green), Iapp (red), or Orx or MCH (blue, top or lower row) in the LH of Pdyn BAC TRAP mice. Scale bar, 100 mm.
(C) Double and triple colocalization betweenOrx, Iapp, and Pdynwere counted from images in (B). A total of 91% Iapp-expressing (Amylin+) neurons were triple-
positive for Orx, amylin, and Pdyn (O+A+P+), while 96.8% were double-positive for Orx and amylin (O+A+) and 92.7% were double-positive for Pdyn and
amylin (A+P+).
(D) IHC for tdTomato (red) and Iapp (green) in the Arc, LH, AP/NTS, and AG from adult ObRb-IRES-Cre and Rosa26-CAG-LSL-tdTomato double-positive mice.
Scale bars, 100 mm.
(E) IHC for Iapp (green) and AgRP or POMC (red, top or lower row) in the Arc from wild-type mice. Scale bars, 50 mm.
(F) IHC for GFP (green), Iapp (red), and Vgat (blue) in the LH of adult ObRb-IRES-Cre and Eef1a1-LSL-eGFP-RPL10a double-positive mice. Scale bar, 5 mm.DISCUSSION
In order to identify transcripts in neurons that control feeding, we
molecularly profiled hypothalamic Pdyn neurons using BAC
TRAP (Heiman et al., 2008). We found that Pdyn neurons
respond to leptin and coexpress many other neuropeptides:
POMC/Cart (Arc),Orx (LH), andAvp,Oxt,Gal, andCrh (PVN). Un-Cell Metabexpectedly, we also identified hypothalamic neurons that ex-
press Iapp, the precursor to amylin. We found that hypothalamic
Iapp expression is positively regulated by leptin and that its
expression is sexually dimorphic in WT mice fed ad lib with reg-
ular chow or HFD. We also found that amylin modulates the ac-
tivity of LH ObRb neurons in a similar manner to leptin and that
CNS amylin acts in concert with leptin to regulate feeding in vivo.olism 22, 1059–1067, December 1, 2015 ª2015 Elsevier Inc. 1061
(legend on next page)
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Overall, these data establish hypothalamic amylin as a neuro-
peptide that is leptin regulated. Finally, the ability of an amylin
antagonist delivered i.c.v. to blunt the response to leptin further
suggests that CNS amylin can modulate leptin’s effects in vivo.
Iapp was originally identified as a pancreatic polypeptide co-
secreted with insulin from b cells (Leffert et al., 1989; Ferrier
et al., 1989). Its anorexic effect has been extensively studied
(Chance et al., 1993, 1991; Lutz et al., 1994; Rushing et al.,
2001), and it has also been shown to potentiate the weight-
reducing effect of leptin and reverse leptin resistance in obese
animals (Roth et al., 2008). Studies on CNS amylin expression
have yielded conflicting results (Leffert et al., 1989; Ferrier
et al., 1989). Consequently, a peripheral mechanism accounting
for amylin’s anorexic effect has been proposed (Riediger et al.,
2004, Potes et al., 2010). In this model, area postrema (AP) is
the primary target of pancreatic amylin and projects to hypotha-
lamic nuclei (Arc, LH, and VMH) that regulate feeding via the
nucleus of the solitary tract, lateral parabrachial nucleus, central
amygdala, and lateral subdivisions of the bed nucleus of the stria
terminalis. Other studies, however, have suggested AP-indepen-
dent pathways (Chance et al., 1991; Lutz et al., 2001). In line with
this, our data confirmed that Iapp-expressing neurons reside in
the hypothalamus (somas in MPO, Arc, and LH; fibers in PVN
and DMH) and other brain regions (Figure S4). The failure to
detect Iapp expression in previous studies likely resulted from
insufficient sensitivity. The Iapp transcript in whole hypothala-
mus is orders of magnitude lower than many other hypothalamic
neuropeptides, but is as abundant as these transcripts when as-
sayed after polysome precipitation from Pdyn neurons (Figures
S2A and S2B). These data indicate that while Iapp expression
in the hypothalamus is sparse, Iapp is expressed at fairly high
levels in neurons that express it.
Our data are consistent with a previously reported sexual
dimorphism of Iapp expression in the MPO of maternally
behaving female rats (Dobolyi, 2009), though we also found
significantly different levels of hypothalamic Iapp expression be-
tween female and male mice. In addition, leptin deficiency mark-
edly reduced hypothalamic Iapp expression in female mice
but not in male which already express low Iapp levels at
baseline. This downregulation was not observed in islet Iapp,
suggesting a tissue-specific mechanism for amylin regulation.
Exogenous leptin significantly elevated hypothalamic Iapp in
both genders, suggesting that leptin regulation is not gender
specific, but the precise mechanism remains unknown. HFD
treatment also led to sexually dimorphic and tissue-specific
modulation of hypothalamic Iapp expression. We speculateFigure 2. Characterization of Hypothalamic Iapp Expression
(A) Normalized hybridization intensity of Iapp probe sets from triplicates of hypoth
TRAP mice (n = 6–8, ***p < 0.001).
(B) Iapp gene expression from quadruplicates of female and male hypothalamic
(C) Iapp gene expression from hypothalamic total RNA extracts of individual WT
(D) Islet Iapp expression from WT and ob/ob female and male mice (n = 3 or 7, *
(E) EIA of plasma amylin from WT and ob/ob female and male mice (n = 4–7, *p
(F) Hypothalamic Iapp expression from leptin or PBS-treated female and male o
(G) Hypothalamic Iapp expression from WT and ob/ob, double- and nontransgen
(H) EIA of plasma amylin from the mice in G (human leptin in double-transgenic m
(I) Hypothalamic Iapp expression from HFD-treated female and male mice (n = 3
(J) Islet Iapp expression from the mice in (I).
(K) EIA of plasma amylin from the mice in (I).
Cell Metabthat HFD-induced leptin resistance underlies this modulation.
Previous studies of the effects of a combination of leptin plus
amylin have only been carried out in male DIO rats, although
this combination reduces body weight in both male and female
human patients (Roth et al., 2008; http://www.takeda.com/
news/2010/20100223_3746.html).
We found that amylin modulates the electrophysiologic activ-
ity of LH ObRb neurons in a manner similar to leptin. These neu-
rons are a heterogeneous population, with 65% being excited
and 35% being inhibited by both leptin and amylin. This correla-
tion is consistent with the synergy between leptin and amylin
in vivo. Furthermore, we found that inhibition of amylin signaling
with AC187 blunted leptin’s effects on both leptin-activated and
leptin-inhibited neurons, suggesting a constitutive activation and
inhibition of LHObRb neurons by CNS amylin. Together with our
IHC data showing putative synaptic structures between amylin
immunopositive fibers and ObRb immunopositive cell bodies,
it is likely that amylin-expressing neurons innervate LH ObRb
neurons directly. Supporting this hypothesis are our unpublished
data showing that calcitonin receptor (Calcr), the core compo-
nent of amylin receptor, is enriched in ObRb neurons (FC =
3.06, corrected p = 3.5e-06). Previous data (Leinninger et al.,
2011) showed that LH neurotensin-expressing ObRb neurons
innervate Orx neurons directly and inhibited them through direct
and indirect pathways. In aggregate, these data suggest a recip-
rocal circuit between LH ObRb and LH Orx/amylin neurons.
However, our data do not exclude the possibility that some amy-
lin immunopositive fibers came from Arc or brain regions outside
the hypothalamus.
Previous studies suggested that amylin-induced pSTAT3 acti-
vation in the VMH, whichmay involve IL-6, underlies amylin’s ad-
ditive or synergistic effect with leptin (Roth et al., 2008; Le Foll
et al., 2015; Moon et al., 2011). Consistent with this, we showed
that i.c.v. AC187 blunt leptin’s anorexic effect in vivo. We also
found that treatment of mice with i.c.v. AC187 increased food
intake in ad lib-fed PBS control mice. This is consistent with
our electrophysiological data showing that AC187 inhibited
endogenous activities of LHObRb neurons in the absence of lep-
tin or amylin. This confirms a functional role of CNS amylin in ex-
erting a tonic effect to modulate leptin signaling and suppress
food intake. Taken together, our data established a role of hypo-
thalamic amylin in modulating the neuronal activity of ObRb-
expressing neurons, providing insight into the mechanistic
interaction between leptin and amylin that may underlie the syn-
ergistic effect of a leptin/amylin combination for the treatment of
obesity. Future studies of mice with a conditional loss of Iapp inalamic WT Input, WT IP, ob Input, and ob IP samples obtained from Pdyn BAC
WT Input and WT IP samples (n = 6–8, **p < 0.01).
and ob/ob, female, and male mice (n = 4, ***p < 0.001).
p < 0.05).
< 0.05, **p < 0.01).
b/ob mice (n = 3 or 4, *p < 0.05).
ic Lap-tTA and Tre-hLeptin mice (n = 4, *p < 0.05, **p < 0.01, ***p < 0.001).
ice and mouse leptin in nontransgenic mice, *p < 0.05, **p < 0.01, ***p < 0.001).
or 4, *p < 0.05).
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Figure 3. Effects of Leptin and Amylin on LH ObRb Neurons
(A) Five minutes (left) and 5 s (right) current-clamp recording of a leptin-depolarizing neuron in the presence of 100 nM leptin or amylin (top or bottom). Black bars,
leptin or amylin.
(legend continued on next page)
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Figure 4. Acute i.c.v. Application of AC187
Temporarily Abolishes Leptin’s Anorexic
Effect
(A) Twenty-four hour accumulated food intake at
1, 2, 4, 8, 12, and 24 hr time points for the four
experimental groups: (1) i.p. leptin+i.c.v. AC187
(red, n = 12), (2) i.p. leptin+i.c.v. PBS (blue, n = 11),
(3) i.p. PBS+i.c.v. AC187 (purple, n = 12), and (4) i.p.
PBS+i.c.v. PBS (green, n = 15). *p < 0.05, **p < 0.01,
and ***p < 0.001.
(B1 and B2) Data at 1 and 2 hr time points were
plotted with appropriate scales.
(C) Detailed food consumption (mean and SEM) at
each time point for all groups.orexin neurons will be needed to establish the molecular mech-
anisms by which amylin receptor signaling influences leptin
signaling in LH ObRb neurons. A fuller understanding of the(B) Example of 5 min (left) and 5 s (right) current-clamp recording of a leptin-hyperpolarizing neuron in the
Black bars, leptin or amylin.
(C) Bath application of leptin and amylin (100 nM each) led to significant increases in membrane potential
p < 0.0001 for leptin; n = 14 or 16, p < 0.001 or 0.05 for amylin), and significant decreases in membrane pote
(n = 12, p < 0.001 for leptin; n = 10, p < 0.01 or 0.001 for amylin). Data for leptin and amylin are not always
(D) Correlation between the effects of amylin and leptin on the membrane potential of ObRb neurons. Data
amylin separate by a washout (n = 13, Spearman Rank correlation r2 = 0.8132, p < 0.01).
(E) 100 nM AC187 significantly blocks the effects of leptin and amylin on membrane potential (p < 0.05 or p
depolarizing neurons. AC187 alone significantly decreasedmembrane potential firing rate (p < 0.0001, n = 13
neuron.
(F) AC187 significantly reduces the effects of amylin and leptin on the membrane potential (p < 0.05 or p <
n = 7–8) of leptin-hyperpolarizing neurons. AC187 alone significantly increased membrane potential (p < 0.0
for leptin and amylin are not from the same neuron.
(G) Voltage-clamp traces showing spontaneous EPSCs in the absence or presence of 100 nM leptin (top le
conditions. Right panel shows mean sEPSC amplitude in the presence or absence of leptin and amylin (p
Cell Metabolism 22, 1059–1067,cellular mechanisms could provide new
approaches to improve leptin signaling
and sensitivity. In summary, we identified
a population of LH Iapp-expressing neu-
rons and established an important role for
central amylin to modulate the activity of
LH ObRb neurons. We further find that
amylin blockade decreases the effects of
leptin on these neurons in vivo and
in vitro, suggesting hypothalamic amylin
acts in concert with leptin. This provides in-
sights into the cellular mechanism that
could underlie the synergistic or additive
effect of leptin and amylin in feeding.
Further genetic studies ablating amylin
production only in the CNS or LH will be
necessary to confirm this.
EXPERIMENTAL PROCEDURES
Mice
All animal experiments were conducted under the
guideline of The Rockefeller University Center
of Comparative Biosciences and NIH. All proce-
dures were approved in protocol 14697 and
13606. Mice were housed at 68F–72F on 12 hr
light-dark cycles.Pdyn BAC TRAP mice were generated as described before (Heiman et al.,
2008) and bred to C57BL/6J (Jackson Laboratories, stock number 000664)
for five generations before use. Transgenic mice were bred to heterozygouspresence of 100 nM leptin or amylin (top or bottom).
and firing rate in leptin-depolarizing neurons (n = 22,
ntial and firing rate in leptin-hyperpolarizing neurons
from the same neuron.
are from neurons sequentially treated with leptin and
< 0.01, n = 9) and firing rate (p < 0.05, n = 6) of leptin-
–14). Data for leptin and amylin are not from the same
0.01, n = 7–8) and firing rate (p < 0.05 or p = 0.1094,
01, n = 17), but not firing rate (p = 0.2188, n = 6). Data
ft or right). Bottom trace shows mean sEPSC in both
= 0.0625 and p > 0.999, n = 7 or 6).
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ob/+ mice (Jackson Laboratories, stock number 000632) to generate trans-
genic ob/ob mice. ObRb-IRES-Cre and Rosa26-CAG-LSL-tdTomato mice
(Jackson Laboratories, stock number 008320 and 007914) were used to
generate mice in which tdTomato was specifically expressed in ObRb-ex-
pressing cells. An Eef1a1-LSL-eGFP-RPL10a mouse (Stanley et al., 2013)
was also used to generate mice in which eGFP-RPL10a was specifically ex-
pressed in ObRb-expressing cells. Lap-tTA (Jackson Laboratories, stock
number 003563), and Tre-hLeptin (Ribeiro et al., 2011) mice were used to
generate double transgenic strains in which constitutive expression of a leptin
transgene led to high levels of plasma leptin in the absence of doxycyclin.
IHC and Fluorescence Imaging
Antibodies against GFP, DynA, Orx, AVP, Oxt, Gal, Crh, AgRP, POMC, MCH,
Th, Vgat, vGlut2, Iapp, and tdTomato were used (see details in Supplemental
Experimental Procedures). Images were acquired using an inverted Zeiss LSM
780 laser scanning confocal microscope. Settings were kept constant for all
images that underwent cell counting by Imaris.
Quantitative Real-Time PCR, Isolation of Pancreatic Islets, Leptin
Infusion, Retro-Orbital Bleeding, and Plasma Hormone
Measurements
Procedures were carried out as previously described (see Supplemental
Experimental Procedures for details).
Lateral Ventricle Cannulation
Single-injection cannula (Plastics 1, C313GS-4/SP, 2.5 mm projection) was in-
serted into the brain (1.2 mm lateral and 0.4 mm back from the bregma) of iso-
fluorane/O2-anesthetized and stereotaxic-anchored (KOPF 942) mice. Wound
healing and home-cage behavior were monitored. Body weight recovery to no
less than 90% of presurgery amount within 7 days was the inclusion criteria.
Acute Feeding Procedure
Cannulated mice were housed on reverse light cycle (10 a.m.–10 p.m. dark).
Food intake and body weight were measured daily to evaluate acclimation.
On the day of experiment, food intake and body weight were measured and
dirty bedding was replaced 2 hr before dark onset. Mice showing normal fluc-
tuations were included. One hour later, mice were given i.c.v. AC187 (5 ug/5ul,
Abcam, ab141150) or PBS through matched cannula internal (Plastics 1,
C313IS-4/SP, 3.5 mm projection). Forty minutes later, mice were given i.p. re-
combinant mouse leptin (1.5 ug/10 ul/g of body weight, Amylin Pharmaceuti-
cals) or PBS in the same order as during i.c.v. injection. Food intake was
measured at 1, 2, 4, 8, 12, and 24 hr after dark onset under red light.
Slice Preparation and Electrophysiology
ObRb-IRES-Cre and Rosa26-CAG-LSL-tdTomato double-positive mice
(3–8 weeks old) were used to patch LH ObRb neurons as described before.
See details in Supplemental Experimental Procedures.
Statistics
Results were expressed as mean ± SEM. Student t test, one-way ANOVA, or
two-way ANOVAwas used to assess the significance of difference of themean
or the comparative analyses. For electrophysiological recordings, when data
were distributed normally (Shapiro-Wilk test), statistical differences were
determined using a two-tailed paired or unpaired Student’s t test. Alternatively,
Wilcoxon tests were used. Differences were considered significant at p < 0.05.
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